key: cord-0973030-v8ibiksx
authors: Sharma, Namisha; Muthamilarasan, Mehanathan; Prasad, Ashish; Prasad, Manoj
title: Genomics approaches to synthesis plant-based biomolecules for therapeutic applications to combat SARS-CoV-2
date: 2020-07-25
journal: Genomics
DOI: 10.1016/j.ygeno.2020.07.033
sha: 8f382386e8a9cf35dc0ba87129b481ddd591759a
doc_id: 973030
cord_uid: v8ibiksx

Abstract COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is devastative to the humankind for which neither vaccines nor precise therapeutic molecules for treatment are identified. The search for new drugs and repurposing of existing drugs are being performed; however, at the same time, research on plants to identify novel therapeutic compounds or testing the existing ones is progressing at a slower phase. In this context, genomics and biotechnology offer various tools and strategies to manipulate plants for producing those complex biopharmaceutical products. This review enumerates the scope for research on plant-based molecules for their potential application in treating SARS-CoV-2 infection. Strategies to edit gene and genome, overexpression and silencing approaches, and molecular breeding for producing target biomolecules in the plant system are discussed in detail. Altogether, the present review provides a roadmap for expediting research on using plants as a novel source of active biomolecules having therapeutic applications.

repurposing of drugs is suggested for testing and application. Currently, antiviral drugs such as Lopinavir/Ritonavir and Remdesivir are predominantly used in the treatment. These commercially synthesized molecules inhibit the virus replication either by regulating the ion channel transport or inhibiting the serine protease activity Choy et al., 2020) . However, the search for novel compounds that could interfere with viral replication, assembly, and spread within the human system is in progress. Devising new molecules through computational and integrative approaches that target one or the other process of virus infection and spread could be an amenable strategy. Still, the chemical synthesis of such a molecule is time-consuming and labor-intensive. Screening of existing molecules for repurposing is already being carried out, but at the same time, studying the plants for novel phytochemicals that possess potential antiviral activity is largely ignored.

Large-scale screening of plants for active antiviral compounds dates to 1952, where around 288 plant extracts were tested for their activity against influenza A virus (Chantrill et al., 1952) . Later, Debiaggi et al. (1988) had shown the antiviral effect of Chamaecyparis lawsoniana on herpes simplex virus type 2. Similarly, Serkedjieva (2003) identified the antiviral effect of Geranium sanguineum extract against influenza A virus, and Asres and Bucar (2005) showed anti-HIV activity of Combretum mole. An aqueous extract of Agrimonia eupatoria and root extract of Boehmeria nivea were reported to inhibit hepatitis B virus (Kwon et al., 2005; Huang et al., 2006) . Kotwal et al. (2005) had demonstrated that an acidic extract of Trifolium species could show a broad-spectrum antiviral activity, including anti-SARS activity. Thus, examining natural antiviral compounds from plants gains momentum in the present scenario. These plant-based therapeutic drugs have several advantages as compared to synthetic molecules. Naturally available biomolecules are safe, economical, and have minimal side effects. Further, if a plant-based compound is found to regulate the COVID-19 infection, it can facilitate an immediate use in the treatment regime after obtaining necessary ethical clearances. However, these compounds might not be stable or produced at minimal levels since they might play limited roles in planta. A holistic approach is required to identify such potential compounds, study the biosynthesis pathway, analyze the genes underlying those pathways, and finetuning them using genomics and biotechnological interventions could promote the use of plants as a source and bio-manufacturer of antiviral compounds in large-scale. While mainstreaming plant-based research to identify biomolecules having anti-SARS-CoV-2 activity itself is in a nascent stage, exploiting the potential plants as biofactories is a long way to go. However, the advent of tools and techniques in plant molecular biology and biotechnology could expedite this process provided a roadmap need to be established towards achieving these targets. Given this, the present review enumerates the plant-based compounds that have been identified and J o u r n a l P r e -p r o o f Journal Pre-proof characterized so far for treating viral infections with emphasis on coronavirus strains. The strategies for the identification of additional compounds, implementing omics tools for the over-production of those compounds, customization of biomolecules, and scaling-up of the process for large-scale production have been elaborated. Altogether, the review provides a roadmap for extrapolating the biomolecule repertoire of plants and use genomics and biotechnological approaches for their production and effective use in SARS-CoV-2 treatments.

Presently, traditional medicines from different parts of the world have been studied for their therapeutic effect against SARS-CoV-2. Traditional medicines-based defense methodology has been used against different human viruses, including SARS-CoV, Ebola, and Zika viruses . Recently, Sehailia and Chemat (2020) had compared the mechanism of infection of SARS-CoV-2 and malaria plasmodium and found that both the pathogens infect the lungs to cause the crystallization of carbon dioxide. Based on this information, artemisinin molecule (sesquiterpene lactone), isolated from Artemisia annua, has been proposed to be used in the treatment of SARS-CoV-2 patients. Artemisinin is popularly used in treating malaria; however, it has also been tested for its activity against different viral diseases, including MERS-CoV and SARS-CoV (Hahn et al., 2018; D'Alessandro et al., 2020) . Currently, WHO has backed the clinical trials on Artemisia annua for its use in treating COVID-19, and collaborative research in this direction is being performed at Max-Planck research center, Germany and Mateon Therapeutics, California.

The use of medicinal plants for treating infectious diseases is found to be associated with the tradition and custom of several populations around the globe. For example, Traditional Chinese Medicine (TCM) is one of the well-studied and documented practices followed in China that has been reported to cure many diseases or infections, including SARS-CoV (Tong et al., 2004; Zhang et al., 2004; Liu et al., 2012) . Approximately 85% of COVID-19 patients were treated with TCM that might act due to a close homology between SARS-CoV-2 and SARS-CoV . These plants could possess active biomolecules that regulate virus accumulation by restricting their multiplication. For example, flavonoids (herbacetin, isobavaschalcone, rhoifolin, pectolinarin, quercetin 3-β-D-glucoside, and epigallocatechin gallate) were found inhibit the enzymatic activity of one of the viral proteases; MERS-CoV 3CL protease and myricetin and scutellarein have the potential to regulate the helices activity of nsP13 (SARS-CoV helicase protein). Yang et al. (2020) properties and can be used for the treatment of COVID-19 (Vellingiri et al., 2020) . For instance, Vitex trifolia and Sphaeranthus indicus, the medicinal plants from Southern India, have been reported to target cytokines, thus reducing the inflammation during respiratory diseases, including SARS-CoV at a concentration of 400 ng/mL (Srivastava et al., 2015) .

Similarly, several species used in the daily diet contain metabolites such as curcumin and quercetin, which were found to interact with proteases of SARS-CoV-2 (Sampangi-Ramaiah et al., 2020). Further, Unani medicine, having an antiviral effect against measles and similar virus disease, has been proposed to provide an inhibitory effect on SARS-CoV-2 (Nikhat and Fazil, 2020) . The antiviral compounds reported so far in plant species are summarized in Table 1 , and their target sites of action on SARS-CoV-2 are shown in Figure 1 . In addition to antiviral activity, plant extracts also possess antioxidant, antipyretic, anti-asthmatic, bronchodilator, expectorant, analgesic, and anti-inflammatory activities that have application in the treatment regime of respiratory diseases (Table 2) . Several herbs have been reported to possess immune-boosting properties, and this includes Ocimum tenuiflorum, Zingiber officinale, Trigonella foenum-graecum, Allium sativum, and Curcuma longa. However, there is no comprehensive study performed to identify the active biomolecules that interact with the immune system of the human body to enhance the resistance to diseases. The prevalence of COVID-19 as a pandemic has mandated research and development for identifying vaccines, therapeutic and diagnostic molecules; however, such searching for those biomolecules in plants is not being performed at the right pace. In case of plant-based vaccines, research is appropriately being carried out to express novel virus-like particles (VLP) in plants that could serve as potential antigens for eliciting immune responses. The prime advantages of plant-based vaccines are their purity (free from human pathogens), low cost for production, transportation, and storage . In case of diagnostic reagents, plants serve as a suitable host for expressing viral proteins to develop assay kits for effective detection and diagnosis of SARS-CoV-2 (reviewed in Capell et al., 2020) . Given this, the review explicitly covers the identification and isolation of plant-based therapeutic molecules and the role of genomics and biotechnology in reaping the maximum benefit out of plants for effective treatment of potential diseases. Thin-Layer Chromatography can assist in fingerprinting of secondary metabolites and separating those metabolites at high-resolution. Computational tools coupled with these platforms, aid in the identification of the metabolites, whose chemical structure can be resolved at high-resolution using several available in silico approaches. For screening the efficacy of these biomolecules and studying the potent inhibitors against coronavirus, computer-aided drug design (CADD) serves as a reliable approach (Wang, 2020; Zhou et al., 2020) as it facilitates a multidimensional study of molecular interactions between putative anti-COVID-19 compounds and target proteins. This approach has suggested the interaction of SARS-CoV-2 encoded proteins with different phytochemicals. 3C-like protease (3CL pro ), also known as Main protease (M pro ) is an attractive target for anti-CoV drug design. It is a cysteine protease and is responsible for cleaving the replicase polypeptide into various functional proteins and essential for virus multiplication. Phenolic compounds such as coumarin, flavones (Khan et al., 2020) , baicalin, cyanidin 3-glucoside, and α-ketoamide-11r Phytochemicals such as Belachinal, Macaflavanone E, and Vibsanol B have been found to restrict the formation of ion channels by oligomerization of 'SARS-CoV2 E', thus inhibiting the virus pathogenesis (Gupta et al., 2020) .

The interaction between Spike (S) Glycoprotein of SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2) receptor is crucial for the entry of SARS-CoV-2 into the human alveolar epithelial cells. Different plant-derived lectins such as Griffithsin and Urtica dioica agglutinin lectin interact with S protein and inhibit the binding onto the host cell (Millet et al., 2016;  J o u r n a l P r e -p r o o f Journal Pre-proof Kumaki et al., 2011) . Simultaneously, phytoestrogens, especially Diadiazin, Genistein, Formontein, and Biochanin A were found to have a high affinity towards the substratebinding domain β (SBDβ) of Heat Shock Protein A5 (HSPA5). It is the host-cell receptor that interacts with S protein of COVID-19 and leads to the entry of the pathogen into the host cell.

These phytoestrogens have been reported to act as competitive inhibitors against Spike protein by binding onto the active site of HSPA5 (Elfiky, 2020) . Recently, Withania somnifera compound, Withanone (Wi-N) was found to weaken the binding between ACE2-RBD complex and was thus proposed to control the virus entry into the host cell (Balkrishna et al., 2020) . Kumar et al. (2020) had also shown that Wi-N and caffeic acid phenethyl ester of W. somnifera interact with the highly conserved protease, M pro of SARS-CoV-2. These reports justify that plant-based anti-COVID drugs could save time and cost for designing/developing new therapeutic molecules; however, large-scale screening of plants for identifying such potential biomolecules is imperative. Such compounds once identified will be processed to the further steps for laboratory trials and clinical trials followed by large-scale production, purification, and application at the end-user level.

Plant biotechnology offers a broad spectrum of production strategies at different levels, Figure   2 illustrates how genomics and biotechnology could intervene in producing plant-based drugs. Next-generation sequencing provides comprehensive information about the genes, non-coding regions, and regulatory elements present in the genome, which enables rapid identification of the genes involved in the biosynthesis of therapeutic molecules. Forward genetics approach of estimating the biomolecule content (or large-scale metabolite profiling) in a given population followed by genotyping (genotyping-by-sequencing, double digest restriction-site associated DNA sequencing, whole-genome resequencing, etc.) will identify J o u r n a l P r e -p r o o f Journal Pre-proof the genomic regions regulating the biosynthesis of individual molecules. These genomic regions (genes/alleles/QTLs) can be effectually used in genomics-assisted breeding for developing elite lines producing higher levels of target molecules. On the other hand, gene cloning enables the isolation and molecular characterization of target genes encoding for active biomolecules that can be transformed into a different plant system (Nicotiana, for example, is a widely used system for plant-based drugs) for the ease of expression, optimization of production and purification. For instance, N. benthamiana is now being used as an efficient system for expressing VLP of SARS-CoV-2 to produce a plant-based vaccine.

Similarly, these heterologous systems can be used to produce the desired biomolecules that could be isolated and purified for further downstream approaches. A few metabolites could be tissue-or development-specific, and therefore, finetuning their expression throughout the life cycle of the respective plant is imperative to ensure a maximum harvest. For example, β-Eudesmol has been found to have antibacterial and antiviral properties; however, its usage as an antiviral drug is limited due to its low level (2.39%) of production in Lauris nobilis (Astani et al., 2011) . Promoter cloning or manipulation of cis-regulatory elements in the promoter regions could provide an amenable solution to this issue. CRISPR/Cas9 approach can be deployed to edit the cis-elements present upstream to the gene(s) for ensuring its expression throughout the life cycle of the target plant. Genetic elements regulating posttranslational events acting on the therapeutic biomolecule of interest should also be studied.

CRISPR/Cas9 method enables precise editing of genes, particularly this applies to knock out the enzymes that utilize the target biomolecule as a precursor for further processing and to facilitate rate-limiting processes for over-production of desired metabolites. Transient approaches, including RNA interference or virus-induced gene silencing, could also assist in finetuning the biosynthetic machinery to achieve a higher level of production. Stable transformation of genes and overexpression in the plant system could be achieved through several approaches existing for genetic transformation. Agrobacterium-mediated transformation is one such reliable approach where the gene of interest is cloned into the Tiplasmid and transferred to a plant for integration into the genome . This approach has been widely used in crop improvement for stress tolerance and agronomic traits. Given the broader application, this could be easily adapted for producing target biomolecules in diverse plant systems, where further downstream processing and purification is easy and straightforward. For instance, extracts of Chinese medicinal plants, Panax ginseng and Magnolia officinalis have anti-inflammatory properties, but since they are endangered species, their use in therapeutics is restricted. In such a case, studying the J o u r n a l P r e -p r o o f Journal Pre-proof biosynthetic pathways and engineering them into a model plant species such as maize, tomato, rice, and tobacco reduces the pressure on parent medicinal plants (Moon et al., 2019) and provides the key to achieve production of beneficial compounds. Some natural compounds may require chemical modifications to increase their potency so that they can be used as a therapeutic drug. For example, a naturally occurring saponin, glycyrrhizin, was found to inhibit the replication of coronavirus, but modifying its glycoside chain enhances the antiviral activity by ten folds (Hoever et al., 2005) . Similarly, increased antiviral activity was observed for tomentins and quercetin-7-rhamnoside as compared to their non-modified precursors (Cho et al., 2013; Choi et al., 2009) . These reports accentuate that biotechnology can also bridge the gap between the identification of naturally derived compound(s) and their usage as the therapeutic drug with a reduced timeline and increased efficacy. Also, the administration of plant-based drugs either through topical application or oral intake reduces the stringencies associated with ultra-high purification and storage issues. This will simultaneously reduce manufacturing as well as downstream processing costs.

Plants are primarily under-studied for their use in therapeutic purposes for treating infectious diseases; however, the traditional medicines have taken complete advantage of the entire plant kingdom. The gap between conventional treatment using herbs and extracts and the knowledge on the bioactive compounds present in those plant extracts, as well as their mode of action leading to disease recovery, needs to be bridged. Advances in science and advent of next-generation scientific research and discovery had delivered several tools, techniques, approaches, and strategies that can be effectually used in dissecting the metabolomic profile of plant species to identify the potential compounds that could possess anti-SARS-CoV-2 activities. Computational methods, including molecular modeling, docking, J o u r n a l P r e -p r o o f Plants are a store house of active metabolites, and identification of these metabolites through targeted and untargeted metabolomics is important. These metabolites can be tested for their antiviral activity and released for treating viral diseases. On the other hand, plant based edible vaccines can be synthesized by expressing viral epitopes in plants.

These vaccines are easy to store and propagate. (Image created using freepik.com). approach is the primary tool for detecting the main bioactive compound and the biosynthetic pathway regulating its synthesis in the plant. The metabolite or protein identified by integration of these approaches is studied for its role against SARS-CoV2. This is achieved either by computational/bioinformatics-based docking between the active compound and virus encoded proteins followed by clinical trials or by purification of the phytochemical through chromatography followed by its clinical trial. Further, by applying biotechnology the concentration of these metabolites can be increased significantly. It includes developing stable transformations in plants or by expressing the synthesis machinery into a heterologous system or using transformed root cultures or through chemical modifications in the active molecule to increase its potency as an antiviral compound.

J o u r n a l P r e -p r o o f

Chrysin suppresses mast cell-mediated allergic inflammation: Involvement of calcium, caspase-1 and nuclear factor-κB

Withanone from Withania somnifera May Inhibit Novel Coronavirus (COVID-19) Entry by Disrupting Interactions between Viral S-Protein Receptor Binding Domain and Host ACE2 Receptor

Recent updates on codeine

Piper nigrum extract ameliorated allergic inflammation through inhibiting Th2/Th17 responses and mast cells activation

Potential Applications of Plant Biotechnology against SARS-CoV-2

The action of plant extracts on a bacteriophage of Pseudomonas pyocyanea and on influenza A virus

Inhibition of SARS-CoV 3C-like protease activity by Theaflavin-3,3′-digallate (TF3). Evid. Based Complementary Altern

Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa

Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus

Protective Effect of Curcumin on Acute Airway Inflammation of Allergic Asthma in Mice Through Notch1-GATA3 Signaling Pathway

Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro

The Use of Antimalarial Drugs against Viral Infection

Antiviral activity of Chamaecyparis lawsoniana extract: study with herpes simplex virus type 2

Crocetin activates Foxp3 through TIPE2 in asthmaassociated treg cells

Natural products may interfere with SARS-CoV-2 attachment to the host cell

Calcium and potassium channels are involved in curcumin relaxant effect on tracheal smooth muscles

Menthol: A natural analgesic compound

,8-Cineol inhibits nuclear translocation of NF-κB p65 and NF-κB-dependent transcriptional activity

In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel

Hairy Root Cultures-A Versatile Tool with Multiple Applications

Artesunate-derived monomeric, dimeric and trimeric experimental drugs -Their unique mechanistic basis and pronounced antiherpesviral activity

Stilbenes as κ-selective, non-nitrogenous opioid receptor antagonists

Antiphlogistic and antipyretic activity of Peucedanum ostruthium

Antiviral activity of glycyrrhizic acid derivatives against SARScoronavirus

Natural source d-αtocopheryl acetate inhibits oxidant stress and modulates atopic asthma in humans in vivo

Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells

Inhibitory effects of L-theanine on airway inflammation in ovalbumin-induced allergic asthma

A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2

Mangosteen xanthones mitigate ovalbumin-induced airway inflammation in a mouse model of asthma

Inhibition of SARS-CoV 3CL protease by flavonoids

Potential Inhibitor of COVID-19 Main Protease (Mpro) From Several Medicinal Plant Compounds by Molecular Docking Study

Antispasmodic, bronchodilator, vasorelaxant and cardiosuppressant effects of Buxus papillosa

Identification of chymotrypsinlike protease inhibitors of SARS-CoV-2 via integrated computational approach

Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human Coronavirus OC43 Infection of MRC-5 Human Lung Cells. Biomolecules 9

Neochlorogenic Acid Inhibits Lipopolysaccharide-Induced Activation and Pro-inflammatory Responses in BV2 Microglial Cells

Transformation of thebaine to oripavine, codeine, and morphine by rat liver, kidney, and brain microsomes

The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase

Developing Covid-19 Vaccines at Pandemic Speed

Agrobacterium-Mediated Genetic Transformation of the Medicinal Plant Veratrum dahuricum

Participation of citral in the bronchodilatory effect of ginger oil and possible mechanism of action

Analgesic and antipyretic activities of an aqueous extract and of the flavone linarin of Buddleia cordata

Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin

Development of Systems for the Production of Plant-Derived Biopharmaceuticals

Viscosine as a Potent and Safe Antipyretic Agent Evaluated by Yeast-Induced Pyrexia Model and Molecular Docking Studies

Overview of Covid-19; its prevention and management in the light of Unani medicine

Use of artemisinin and its derivatives for the treatment of Malaria in children

Usnic acid and diffractaic acid as analgesic and antipyretic components of Usnea diffracta

Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases

Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors

Identification and Characterization of Baicalin as a Phosphodiesterase 4 Inhibitor

The analgesic and anti-inflammatory effects of Salvinorin A analogue βtetrahydropyran Salvinorin B in mice

SARS-CoV-2: the emergence of a viral pathogen causing havoc on human existence

Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules

Folium Sennae and emodin reverse airway smooth muscle contraction

Antipyretic and antinociceptive potential of extract/fractions of Potentilla evestita and its isolated compound

3-Methoxy-catalposide inhibits inflammatory effects in lipopolysaccharide-stimulated RAW264.7 macrophages

SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii

Histamine (H1) receptors, cyclooxygenase pathway and nitric oxide formation involved in rat tracheal smooth muscle relaxant effect of berberine

Molecular docking analysis of selected natural products from plants for inhibition of SARS-CoV-2 main protease

In-silico Studies of Antimalarial-agent Artemisinin and Derivatives Portray More Potent Binding to Lys353 and Lys31-Binding Hotspots of SARS-CoV-2 Spike Protein than Hydroxychloroquine: Potential Repurposing of Artenimol for COVID-19

Influenza virus variants with reduced susceptibility to inhibition by a polyphenol extract from Geranium sanguineum L

High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses

Luteolin Attenuates Airway Mucus Overproduction via Inhibition of the GABAergic System

Homoegonol attenuates the asthmatic responses induced by ovalbumin challenge

Diallyl-disulfide, an organosulfur compound of garlic, attenuates airway inflammation via activation of the Nrf-2/HO-1 pathway and NF-kappaB suppression

Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer

A novel triterpenoid 16-hydroxy betulinic acid isolated from Mikania cordata attributes multi-faced pharmacological activities

Synthesis and evaluation of novel analogues of mangiferin as potent antipyretic. Asian Pac

A novel anti-inflammatory natural product from Sphaeranthus indicus inhibits expression of VCAM1 and ICAM1, and slows atherosclerosis progression independent of lipid changes

Investigation into SARS-CoV-2 Resistance of compounds in garlic essential oil

Sabadinine: a potential nonpeptide anti-severe acute-respiratory-syndrome agent identified using structure-aided design

TCM treatment of infectious atypical pneumonia--a report of 16 cases

The mechanism of action of aspirin

Phenacetin isolated from Bursera grandifolia, a herbal remedy with antipyretic properties

COVID-19: A promising cure for the global panic

Cannabinoids and pain: New insights from old molecules

Antitussive, expectorant and anti-inflammatory activities of four alkaloids isolated from Bulbus of Fritillaria wabuensis

Fitoterapia Antitussive , expectorant and anti-in fl ammatory alkaloids from Bulbus Fritillariae Cirrhosae

Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Evaluation of pharmacological relaxation effect of the natural product naringin on in vitro cultured airway smooth muscle cells and in vivo ovalbumin-induced asthma Balb/c mice

Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication

Antitussive, expectorant, and antiinflammatory activities of four caffeoylquinic acids isolated from Tussilago farfara

Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective

Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells

Expectorant , antitussive , anti-in fl ammatory activities and compositional analysis of Aster tataricus

Effect of integrated traditional Chinese and Western medicine on SARS: a review of clinical evidence

Anti-asthmatic effects of oxymatrine in a mouse model of allergic asthma through regulating CD40 signaling

Inhibition of allergic airway inflammation through the blockage of NF-κB activation by ellagic acid in an ovalbumin-induced mouse asthma model

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection

Imperialine, imperialine-β-Noxide, isoverticine, and isoverticine-β-

Alkaloids Unknown Wang et al., 2012 J o u r n a l P r e -p r o o f